JAZZ logo

Jazz Pharmaceuticals (JAZZ) Depreciation and amortization

annual D&A:

$660.07M+$21.37M(+3.35%)
December 31, 2024

Summary

  • As of today (May 20, 2025), JAZZ annual depreciation & amortization is $660.07 million, with the most recent change of +$21.37 million (+3.35%) on December 31, 2024.
  • During the last 3 years, JAZZ annual D&A has risen by +$107.58 million (+19.47%).
  • JAZZ annual D&A is now at all-time high.

Performance

JAZZ Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

quarterly D&A:

$164.87M-$3.54M(-2.10%)
March 1, 2025

Summary

  • As of today (May 20, 2025), JAZZ quarterly depreciation & amortization is $164.87 million, with the most recent change of -$3.54 million (-2.10%) on March 1, 2025.
  • Over the past year, JAZZ quarterly D&A has increased by +$1.49 million (+0.91%).
  • JAZZ quarterly D&A is now -8.26% below its all-time high of $179.71 million, reached on March 31, 2022.

Performance

JAZZ quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

TTM D&A:

$661.56M+$1.49M(+0.23%)
March 1, 2025

Summary

  • As of today (May 20, 2025), JAZZ TTM depreciation & amortization is $661.56 million, with the most recent change of +$1.49 million (+0.23%) on March 1, 2025.
  • Over the past year, JAZZ TTM D&A has increased by +$16.84 million (+2.61%).
  • JAZZ TTM D&A is now -0.98% below its all-time high of $668.11 million, reached on June 30, 2022.

Performance

JAZZ TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

JAZZ Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.4%+0.9%+2.6%
3 y3 years+19.5%-8.3%+0.3%
5 y5 years+78.3%+144.7%+75.4%

JAZZ Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+19.5%-8.3%+13.9%-1.0%+9.0%
5 y5-yearat high+137.2%-8.3%+144.7%-1.0%+137.8%
alltimeall timeat high>+9999.0%-8.3%+8394.2%-1.0%>+9999.0%

JAZZ Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$164.87M(-2.1%)
$661.56M(+0.2%)
Dec 2024
$660.07M(+3.3%)
$168.42M(+1.9%)
$660.07M(+1.4%)
Sep 2024
-
$165.23M(+1.3%)
$650.85M(+0.4%)
Jun 2024
-
$163.03M(-0.2%)
$648.18M(+0.5%)
Mar 2024
-
$163.38M(+2.6%)
$644.72M(+0.9%)
Dec 2023
$638.70M(+1.5%)
$159.20M(-2.1%)
$638.70M(+2.3%)
Sep 2023
-
$162.56M(+1.9%)
$624.23M(+2.2%)
Jun 2023
-
$159.58M(+1.4%)
$610.49M(+0.6%)
Mar 2023
-
$157.36M(+8.7%)
$607.12M(-3.6%)
Dec 2022
$629.47M(+13.9%)
$144.73M(-2.8%)
$629.47M(-3.1%)
Sep 2022
-
$148.83M(-4.7%)
$649.36M(-2.8%)
Jun 2022
-
$156.20M(-13.1%)
$668.11M(+1.3%)
Mar 2022
-
$179.71M(+9.2%)
$659.22M(+19.3%)
Dec 2021
$552.48M(+98.6%)
$164.62M(-1.8%)
$552.48M(+20.2%)
Sep 2021
-
$167.58M(+13.8%)
$459.54M(+26.4%)
Jun 2021
-
$147.31M(+101.9%)
$363.45M(+28.0%)
Mar 2021
-
$72.97M(+1.8%)
$283.85M(+2.0%)
Dec 2020
$278.25M(-24.8%)
$71.67M(+0.2%)
$278.25M(-27.6%)
Sep 2020
-
$71.49M(+5.6%)
$384.53M(+1.2%)
Jun 2020
-
$67.71M(+0.5%)
$379.89M(+0.7%)
Mar 2020
-
$67.37M(-62.1%)
$377.11M(+1.9%)
Dec 2019
$370.16M(+70.8%)
$177.95M(+166.2%)
$370.16M(+52.6%)
Sep 2019
-
$66.85M(+3.0%)
$242.62M(+7.0%)
Jun 2019
-
$64.93M(+7.5%)
$226.66M(+2.8%)
Mar 2019
-
$60.42M(+19.9%)
$220.43M(+1.7%)
Dec 2018
$216.73M(+31.2%)
$50.41M(-0.9%)
$216.73M(-2.8%)
Sep 2018
-
$50.90M(-13.3%)
$223.02M(+0.2%)
Jun 2018
-
$58.69M(+3.5%)
$222.50M(+15.2%)
Mar 2018
-
$56.73M(+0.0%)
$193.09M(+16.9%)
Dec 2017
$165.15M(+45.2%)
$56.70M(+12.6%)
$165.15M(+19.5%)
Sep 2017
-
$50.38M(+72.1%)
$138.24M(+17.7%)
Jun 2017
-
$29.28M(+1.7%)
$117.43M(+0.0%)
Mar 2017
-
$28.80M(-3.3%)
$117.41M(+3.2%)
Dec 2016
$113.78M(+5.3%)
$29.78M(+0.7%)
$113.78M(+3.0%)
Sep 2016
-
$29.57M(+1.1%)
$110.44M(+0.8%)
Jun 2016
-
$29.25M(+16.2%)
$109.54M(+3.0%)
Mar 2016
-
$25.17M(-4.8%)
$106.32M(-1.6%)
DateAnnualQuarterlyTTM
Dec 2015
$108.06M(-19.2%)
$26.44M(-7.8%)
$108.06M(-6.6%)
Sep 2015
-
$28.68M(+10.2%)
$115.65M(-3.2%)
Jun 2015
-
$26.03M(-3.3%)
$119.47M(-6.7%)
Mar 2015
-
$26.91M(-20.9%)
$128.10M(-4.2%)
Dec 2014
$133.68M(+62.8%)
$34.04M(+4.7%)
$133.68M(+10.3%)
Sep 2014
-
$32.50M(-6.2%)
$121.15M(+11.0%)
Jun 2014
-
$34.66M(+6.7%)
$109.11M(+15.5%)
Mar 2014
-
$32.49M(+51.1%)
$94.45M(+15.1%)
Dec 2013
$82.09M(+10.6%)
$21.51M(+5.1%)
$82.09M(-1.1%)
Sep 2013
-
$20.46M(+2.3%)
$83.01M(-2.0%)
Jun 2013
-
$19.99M(-0.7%)
$84.67M(+5.0%)
Mar 2013
-
$20.13M(-10.2%)
$80.66M(+8.7%)
Dec 2012
$74.23M(+848.4%)
$22.43M(+1.4%)
$74.23M(+38.0%)
Sep 2012
-
$22.12M(+38.4%)
$53.78M(+60.1%)
Jun 2012
-
$15.98M(+16.7%)
$33.59M(+71.7%)
Mar 2012
-
$13.70M(+594.3%)
$19.56M(+149.9%)
Dec 2011
$7.83M(-10.1%)
$1.97M(+1.6%)
$7.83M(-0.8%)
Sep 2011
-
$1.94M(-0.3%)
$7.89M(-1.4%)
Jun 2011
-
$1.95M(-1.0%)
$8.00M(-3.9%)
Mar 2011
-
$1.97M(-3.4%)
$8.32M(-4.5%)
Dec 2010
$8.71M(-4.2%)
$2.04M(-0.7%)
$8.71M(-3.8%)
Sep 2010
-
$2.05M(-9.6%)
$9.06M(-3.9%)
Jun 2010
-
$2.27M(-3.8%)
$9.43M(+0.8%)
Mar 2010
-
$2.36M(-1.0%)
$9.35M(+2.8%)
Dec 2009
$9.10M(-39.5%)
$2.38M(-1.6%)
$9.10M(-13.6%)
Sep 2009
-
$2.42M(+10.5%)
$10.53M(-13.7%)
Jun 2009
-
$2.19M(+4.2%)
$12.20M(-15.7%)
Mar 2009
-
$2.10M(-44.9%)
$14.48M(-3.6%)
Dec 2008
$15.03M(+42.8%)
$3.81M(-7.0%)
$15.03M(+8.2%)
Sep 2008
-
$4.10M(-8.4%)
$13.88M(+11.9%)
Jun 2008
-
$4.47M(+69.1%)
$12.40M(+17.6%)
Mar 2008
-
$2.65M(-0.9%)
$10.55M(+0.2%)
Dec 2007
$10.53M(+2.1%)
$2.67M(+1.8%)
$10.53M(+34.0%)
Sep 2007
-
$2.62M(+0.2%)
$7.86M(+50.0%)
Jun 2007
-
$2.61M(-0.4%)
$5.24M(+99.6%)
Mar 2007
-
$2.62M
$2.62M
Dec 2006
$10.31M(+89.6%)
-
-
Dec 2005
$5.44M
-
-

FAQ

  • What is Jazz Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual D&A year-on-year change?
  • What is Jazz Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly D&A year-on-year change?
  • What is Jazz Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals TTM D&A year-on-year change?

What is Jazz Pharmaceuticals annual depreciation & amortization?

The current annual D&A of JAZZ is $660.07M

What is the all time high annual D&A for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual depreciation & amortization is $660.07M

What is Jazz Pharmaceuticals annual D&A year-on-year change?

Over the past year, JAZZ annual depreciation & amortization has changed by +$21.37M (+3.35%)

What is Jazz Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of JAZZ is $164.87M

What is the all time high quarterly D&A for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly depreciation & amortization is $179.71M

What is Jazz Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, JAZZ quarterly depreciation & amortization has changed by +$1.49M (+0.91%)

What is Jazz Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of JAZZ is $661.56M

What is the all time high TTM D&A for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high TTM depreciation & amortization is $668.11M

What is Jazz Pharmaceuticals TTM D&A year-on-year change?

Over the past year, JAZZ TTM depreciation & amortization has changed by +$16.84M (+2.61%)
On this page